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Enterovirus protein 2B has been shown to increase plasma membrane permeability. We have identified a 
conserved putative amphipathic a-helix with a narrow hydrophilic face and an arrangement of cationic 
residues that is typical for the so-called lytic polypeptides. To examine the functional and structural roles of 
this putative amphipathic a-helix, we have constructed nine coxsackie B3 virus mutants by site-dirccted 
mutagenesis of an infectious cDNA clone. Six mutants contained substitutions of the charged residues in the 
hydrophilic face of the a-helix. Three mutants contained insertions of leucine residues between the charged 
residues, causing a disturbance of the amphipathic character of the a-helix. The eifect of the mutations on virus 
viability was assayed by transfection of cells with copy RNA transcripts. The effect on positive-strand RNA 
replication was examined by introduction of the mutations in a subgenomic luciferase replicon and analysis of 
luciferase accumulation following the transfection of BGM cells with RNA transcripts. It is shown that both the 
amphipathy of the domain and the presence of cationic residues in the hydrophilic face of the a-helix are 
required for virus growth. Mutations that disturbed either one of these features caused defects in viral RNA 
synthesis. In vitro translation reactions and the analysis of viral protein synthesis in vivo demonstrated that 
the mutations did not affect synthesis and processing of the viral polyprotein. These results suggest that a 
cationic amphipathic a-helix is a major determinant for a function of protein 2B, and possibly its precursor 
2BC, in viral RNA synthesis. The potential role of the amphipathic a-helix in the permeabilization of cellular 
membranes is discussed.
Enteroviruses contain a single-stranded RNA genome of 
positive polarity with a genetically encoded poly(A) tail at their 
3' end. The viral RNA (vRNA) directs the synthesis of a single 
polyprotein which is processed by the virally encoded proteases 
2Apro, 3Cpro, and 3CDpro. The PI region of the genome en­
codes the structural capsid proteins. The proteins encoded by 
the P2 and P3 regions have been implicated in viral replication 
(reviewed in reference 47). Replication starts by the formation 
of a complementary negative-stranded RNA molecule which 
serves as the template for the synthesis of progeny viral posi­
tive-stranded RNAs (5). The proteins encoded by the P3 re­
gion are physically involved in the process of positive-strand 
RNA synthesis (3, 22, 42, 43), which occurs in replication 
complexes on virus-induced cytoplasmic membrane vesicles 
(8). The proteins encoded by the P2 region are involved in the 
induction of some of the structural and metabolic alterations 
that occur in the infected cell. Protein 2Apro induces the cleav­
age of the 220-kDa component of the eucaryotic initiation 
factor eIF-4F, which results in an inhibition of cap-dependent 
host cell translation (18, 20, 29). Translation of viral RNA is 
not affected, because it is initiated via a cap-independent bind­
ing of ribosomes to secondary structures in the 5' nontrans- 
lated region (26, 35). Precursor protein 2BC has been impli­
cated in the rearrangement of membranes and the generation 
of the membrane vesicles at which positive-strand RNA syn­
thesis occurs (7-10). The observation that protein 2C alone is 
also capable of inducing this rearrangement (2 , 14) is ham­
pered by the use of a recombinant vaccinia virus, which mod­
ifies vesicular traffic itself. Protein 2C is a nucleoside triphos­
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phatase (33, 39) with RNA binding capacities (39) that is 
localized at the outer surface of the virus-induced membrane 
vesicles (7, 9, 10), which suggests that protein 2C may be 
involved in the structural organization of the viral replication 
complex by attaching the vRNA to the vesicular membranes, 
Two other metabolic alterations that occur during an en­
terovirus infection are the inhibition of cellular protein secre­
tion (16) and the permeabilization of the plasma membrane 
(12). Upon expression of individual poliovirus proteins, Doe- 
dens and Kirkegaard found that protein 2B, as well as its 
precursor 2BC, was capable of inducing both alterations (16). 
The significance of these alterations, which become evident 
from the third-hour postinfection, for virus replication is un­
clear. The block in protein secretion may be involved in the 
accumulation of cytoplasmic vesicles for vRNA synthesis. 
Apart from this, the inhibition of cellular protein secretion may 
interfere with host cell responses such as interferon secretion 
and antigen presentation. Modification of membrane perme­
ability occurs in the late phase of infection of most cytolytic 
viruses and requires viral gene expression (reviewed by 
Carrasco et al. in reference 13). The modification is such that 
gradients of monovalent cations are gradually destroyed and 
compounds that normally do not pass the membrane leak out 
of the cell or leak into the cytoplasm. Carrasco et al. (13) have 
suggested that the resulting influx of sodium ions may be in­
volved in the virus-induced shutoff of host cell translation, 
because the cleavage of the 220-kDa component of eIF-4F may 
not be sufficient to completely shut off host cell translation (11, 
36). High concentrations of sodium are inhibitory to host 
mRNA translation, whereas viral RNA is optimally t ra n s la ted  
under these altered conditions by the use of specialized struc­
tures in the 5' nontranslated region (13). Another function of 
the membrane modification may be the induction of the cell 
lysis needed to liberate newly formed virus particles.
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E n te ro v iru s  protein 2B and i ts  precursor 2BC are localized 
exclusively at the outer surface of the virus-induced membrane 
vesicles at which positive-strand synthesis occurs (7, 8). Ge­
netic evidence suggests that protein 2B, or possibly its precur­
sor 2BC, is required for a ov-acting function in vRNA repli­
cation (27, 46). The expression of protein 2B in both bacteria 
and eucaryotic cells led to an increase in cell membrane per­
meability, which suggests that protein 2B possesses membrane- 
active or ionophoric properties. Both functions require amphi­
pathic helix motifs with high helical hydrophobic moments
(19), We have identified a well-conserved amphipathic helix 
motif in enterovirus protein 2B with a narrow hydrophilic face 
and an arrangement of cationic residues that is typical for the 
so-called lytic polypeptides. The conserved nature of this struc­
tural domain is indicative of an important role in the function­
ing of protein 2B. To examine the structural and functional 
roles o f  this putative amphipathic a-helix, we have constructed 
mutant coxsackie B3 virus cDNAs that contained substitutions 
of the charged residues in the hydrophilic face or insertions of 
hydrophobic leucine residues that disturb the amphipathic 
character of the helix. The effects of the mutations on virus 
viability, RNA synthesis, viral protein synthesis, and polypro­
tein processing were examined. Our results indicate that a 
cationic amphipathic a-hclix is indeed required for a function 
of protein 2B> and possibly also its precursor 2BC, in vRNA 
synthesis but not for viral protein synthesis or polyprotein 
processing. The potential role of the amphipathic a-helix in the 
permeabilization of the plasma membrane is discussed.
MATERIALS ANI) METHODS
Cells and viruses. Virus propagations, endpoint titrations, and RNA transfec­
tions were performed with Bullalo green monkey (BGM) cells. Plaque assays 
were performed with Vein cells. The cells were grown in minimal essential 
medium (MEM) supplemented with 10% fetal bovine serum. After infection, the 
cells were fed with MEM supplemented with 3% fetal bovine serum. After 
transfection, the cells were fed with MEM containing 10% fetal bovine scrum.
Oligonucleotide-directed site-specific mutagenesis. In vitro mutagenesis was 
performed with n subgenomic pALTER phagemid clone containing nucleotides 
(nt) 2080 to 4947 of coxsackie B3 virus (CBV3) (46), using the Altered Sites in 
vitro mutagenesis system (Promega) according to the instructions of the manu­
facturer. The nucleotide sequences of the antisense synthetic oligonucleotides 
(Isogen Bioscience, The Netherlands) used for construction of the mutants 
(shown in parentheses) are as follows: 5 '-TGATATTATCCTAACTAAGG 
CTCTTAGAGATCTCTCTAAGAT-3' (2B-K[4l.44,48]R [This mutant contains 
K-to-R mutations at positions 41, 44. and 48]); 5 '-TGATATTATCTCAACTAAG 
GCrrCTAGAGATTCCTCTAAGAT-3' (2B-K[41,44,48]E); 5'TAAGGCTTTTA 
GAG AG AG CTCTA AG ATG Ci A GTC-3' (2B-K[41]L); 5' -TATC1TA ACTAAG 
GCTAGCAGAGAGAGCTCTAAGATGGAGTC-3' (2B-K[4l,441L); 5'-TTITA 
GAGATTTCTTTAAAATGGAGTCTTGACC-3' (2B-E[40]K); S '-G G C m T A G  
AG ATTTGTCTAG A ATG G AGTCIT G ACCC AC-3' (2B-E[40]D); 5'-AACTAA 
GGCnTfAGAGACTFAAGCrCTAAGATGGAGTCTTGACC-3' (2B-ins[41] 
L); 5 ’ -TATTAT CTTA A CTA AG G CCTTA AG TAG A G ATTTCTCTA AG ATG G 
A-3' (2B-ins[44]L); and S'-TACTAAGGCrGATATTATCTTAAGAACTAAG 
G un fTAGAGATTT-3' (2B-ins[48]L). Each of these oligonucleotides created a 
novel restriction endonuclease site. Mutant clones were identified by restriction 
enzyme analysis. The nucleotide sequences of the mutant pALTER clones were 
verified by dideoxy chain termination sequencing of plasmid DNA with the 
oligonucleotide 5' -CCATTCA ATG A ATTTCTG-3' (nt 4117 to 4134), using the 
Ampli Cycle sequencing kit according to the instructions of the manufacturer 
(Perkin-Elmer). The 4l)2-bp ,fy>d-lo-EwITII fragments of the mutant clones were 
introduced in the unique Spel (nt 3837) and flwHII (nt 4238) sites of plasmid 
pCB3/T7 which contains a cDNA of CBV3 (strain Naney) behind a T7 RNA 
polymerase promoter (28).
Construction of plasmid 211-boinll. Nucleotides 3862 to 3906 of pCB3/T7 
(coding sequence for protein 2B amino acids [aa] 40 to 55) were replaced by 
45 nt encoding 15 aa of bombolitin FI by using PCR with the synthetic 
105-mer 5'-GAATCACTAGTGGGTCAAGACTCCATCTTAAGCAAGAT
^ ffiA T A T C C T rO C G A  A O rT T nO A A A A G T A C T G G C C A TTGTGGT 
GAGGAACCACGATGACCTGATC-3' (nt 3832 to 3936; nucleotides encod­
ing the bombolitin 11 amino acids are underlined) and the oligonucleotide 
5'-TTGGGATGGCGCGCTCTGCTC-3' (complementary to nt 4231 to 
4251). PCRs were performed with ULTma DNA polymerase (Perkin-Elmer), 
a thermostable DNA polymerase with proofreading activity, and pCB3/T7 
DNA as the template DNA. The thermal profile consisted of 20 cycles of
dénaturation at 94°C for 1 min, prim er annealing at 55°C for 1 min, and 
primer extension at 72°C for 2 min. The resulting PCR product was cut with 
SpeI and /fasHII and cloned in pCB3/T7 cut with the same enzymes. The 
entire introduced fragment was verified by sequence analysis. The resulting 
plasmid was designated 2B-bomII.
Transaction of cells with copy RNA transcripts. Plasmids were linearized with 
Sail and transcribed by phage T7 R N A  polymerase as described previously (46). 
The integrity of the RNA transcripts was checked on a 1 % agarose gel. BGM cell 
monolayers grown in 25-cm2 flasks to a conflueney of 70 to 80% were transfected 
with 5 jxg of RNA transcripts by the DEAJE-dextran method as described p re­
viously (46). After transfection, the cells were incubated at either 33 or 36°C. 
When virus growth was observed, the cultures were incubated until cytopathic 
effect was complete. The cultures were then subjected to three cycles of freezing 
and thawing, and the viruses were aliquotcd in stocks of I ml and stored al
-80°C.
Sequence analysis of the 2B coding region of m utan t viruses. Extraction of 
RNA, cDNA synthesis, and amplification by PCR were performed as described 
previously (46), using forward primer 5' -TGGTGTCATTGGCATTGTGAC 
CATGGGGGG-3' (nt 3648 to 3677) and reverse primer 5 '-TTG G G A TG G C 
GCGCTCTGCTC-3' (nt 4231 to 4251). The resulting 604-bp PCR products were 
purified by low-melting-point agarose gel electrophoresis. Sequence analysis was 
performed as described above,
Plaque assays and single-cycle growth analysis. Plaque assays were performed 
with 100% confluent Vcro cell monolayers grown in 6-well plates as described 
previously (46). For single-cycle infections, 100% confluent BGM cell monolay­
ers grown in 25-cm2 flasks (5 X 106 cells) were infected with virus at a multiplicity 
of infection (MOI) of 1 50% tissue culture infective dose per cell for 30 min at 
room temperature. The cells were grown at 33, 36, or 39°C for 2, 4, 6, or 8 h. 
Viruses were released by three cycles of freezing and thawing. Viruses were 
titrated on BGM cell monolayers in 96-well plates, as previously described (46). 
50% tissue culture infective dose values were calculated according to the method 
of Reed and Mueneh (38).
Analysis of RNA synthesis. To study the effect of the mutations on RNA 
synthesis, the Spel-to-BssHll fragments of the mutant plasmids were cloned in 
the chimeric subgenomic replicon pCB3/T7-LUC (46), which contains the firefly 
luciferase gene in place of the capsid coding PI region. BGM cell monolayers in 
25-cm2 flasks grown to a confluency of 70 to 80% were transfected with 0.5 fxg of 
T7 RNA polymerase-generated RNA transcripts derived from Srt/I-linearized 
pCB3/T7-LUC constructs. The cells were grown at 36°C, and at the indicated 
times posttransfection they were washed three times with phosphate-buffered 
saline (PBS) and lysed in 400 \il of lysis buffer. The luciferase activity was 
measured in a liquid scintillation counter by using the Luciferase Assay System 
according to the recommendations of the manufacturer (Promega).
In vitro translation reactions. Copy RNA transcripts were synthesized and 
translated in T7 TNT rabbit reticulocyte lysate (Promega) supplemented with 
20% (vol/vol) HeLa cell initiation factors (kindly provided by J. Flanegan, Uni­
versity of Florida). The translation reaction mixtures (20 ¡xl) con ta ined0.5 jxgof 
circular plasmid DNA and 20 (jlCî of Tran35S-label (a mixture of [35SJmethioninc 
and [35S]cysteine; specific activity, >1,000 Ci/mmol; ICN). After 3 h of incuba­
tion al 30°C, RNA was degraded by treatment with RNase T * (500 U) and RNase 
A (5 (J-g) for 10 min at 30°C. Labeled translation products were analyzed on a 
12.5% polyacrylamide gel containing sodium dodecyl sulfate (SDS) (30). The 
gels were fixed, fluorographed, and exposed to Kodak XAR film al -80°C.
Analysis of viral protein synthesis in vivo. BGM monolayers (2 X 105 cells) 
were infected with either wild-type or mutant virus at a MOI of 25. At the 
indicated times postinfection, the cells were washed with PBS and incubated in 
methionine- and serum-free MEM (Gibco) containing 10 p^Ci of Tran35S-label. 
After 30 min, the medium was removed and the cells were lysed in cold lysis 
buffer containing 500 mM Tris HC1 (pH 8.0), 150 mM NaCI, 0.1 mM phenyi- 
methylsulfanyl fluoride, 1% Nonidet P-40, and 0.05% SDS. Labeled proteins 
were analyzed by polyacrylamide gel electrophoresis as described above.
RESULTS
Identification and classification of a putative amphipathic 
helix in enterovirus protein 2B. We have searched for the 
presence of amphipathic helix motifs in CBV3 protein 2B by 
calculating the mean hydrophobic moment and hydrophobicity 
of 11-residue windows according to the method of Eisenberg et 
al. (19). Figure 1 shows that amino acids 37 to 54 form the 
segment with the highest amphipathic potential. The high hy­
drophobic moment and the moderate hydrophobicity of the 
11-residue segment with the highest hydrophobic moment (aa 
40 to 50; moment, 0.67; hydrophobicity, 0 .11) are characteristic 
of surface-seeking amphipathic helices (19), i.e., helices which 
insert their hydrophobic part in the lipid membrane and ex­
pose their hydrophilic part to the aqueous face. Graphic rep- 
resentation with a helical wheel diagram according to Schilfer
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P I  r e g i o n F2 r e g i o n T P3 r e g i o n
VPg—— 5 ' NTR-- VP 4 VP 2 VP 3 VP1 2A 2B 20 3A 3C 3D
3B
3 ' NTR- (A).
ÜO S aa motn. hvd . DOS aa mom. h v d . DOS aa mom. hyd.
1 G 34 G 0 .18 0 .06 67 T
0 .21  + 0.53
2 V 35 Q 0 .13 0 .13 68 A 0 .1 1  + 0.74
3
T
K 36 D 0 .15 0 .06 69 T 0 .05  + 0.68
4 D 37 S 0 .15 0 ,06 70 L 0 ,1 3  + 0.59
5 Y 38 I 0 .12 0 .06 71 A 0 .12  + 0.59
6 V * 0. 54 -0 .03 39 L 0 .34 -0.17 72 L 0 .01 0.47
7 E * 0 .56 -*0.02 40 E 0 .36 -0.15 73 I 0 .02 0.46
8 Q * 0. 56 -0 .01 41 K
★ 0 .52 0 .02 74 G 0 .06 0.41
9 L * O. 53 0 .17 42 S * 0 .50 0 .20 75 C 0 ,13 0.49
10 G * 0 .4 6 0 .24 43 L * * 0 .62 + 0 ,08 76 T 0 .32 0.17
11 N * 0 .4 8 0 .26 44 K * * 0 .66 + 0 ,08 77 S 0 .34 0,18
12 A * 0 .47 0 .27 45 A ** 0 .67 + 0 .11 78 S 0 .34 0.18
13 P * D. 44 0 .33 46 L ** 0 .66 + 0 ,16 79 P
a 0 .43 -0.08
14 G 0 .4 1 0 .3 4 47 V * 0 .51 + 0 ,35 80 W
* 0 .52 -0.20
15 S 0 .29 0 .1 6 48 K * * 0 .61 •h 0 .46 81 R 0 .40 —0.36
16 G 0 .3 4 0 .2 5 49 I * 0 .58 + 0 .46 82 W
★ 0.47 -0.26
17 F 0 .29 0 .3 4 50 I 0 .33 0 ,73 83 L * 0 .47 -0.25
18 T 0 .39 0 .  22 51 S 0 .35 + 0 .77 84 Q * 0 .50 -0.32
19 N 0. 33 0 .03 52 A 0 .35 + 0 .77 85 K * 0 .51 -0.31
20 Q 0 .3 7 0 .0 9 53 L * 0 .53 + 0 .44 86 Q * 0 .48 -0.36
21 I 0 .4 1 0 .03 54 V * 0 .47 + 0 .51 87 V 0 .23 -0.08
22 c 0. 39 0 .09 55 X 0 .33 0 ,34 88 S 0 .26 -0.03
23 E 0.  40 0 .07 56 V 0 .31 0 .14 89 Q 0 .17 -0.12
24 Q 0 .3 8 - 0 .06 57 V 0 .37 0 .07 90 Y 0 .24 0.07
25 V 0. 38 -0 .05 58 R 0 .41 0 .11 91 Y 0 .15 0.21
26 N 0. 37 0 .0 1 59 N 0 ,41 0 .14 92 G 0 .07 0.28
27 L 0 .33 -0 .02 60 H * 0 ,48 0 .04 93 I 0 .26 —0.05
2 8 L 0 .  38 0 . 0 5 6 1 D * 0 . 5 2 0 . 0 1 9 4 P 0 . 2 3 -0.11
2 9 K 0 . 1 9 0 . 1 6 6 2 D * 0 . 4 3 - 0 .  09 95 M
3 0 E 0. 18 0 .1 6 63 L 0 .40 -0.13 96 A
31 S 0 .22 - 0 .02 64 Ü» 0 .18 0 .09 97 E
32 L 0. 17 0 .04 65 T 0 .26 0 .26 98 R
33 V 0 .2 1 0 .0 6 66 V 0 .31 0 .35 99 Q
FIG. 1. Analysis of the hydrophobic moment (amphipathy) and hydrophobicity of CBV3 protein 2B according lo the method of Eisenberg el al. (19), The 
hydrophobic moment (mom.) and hydrophobicity (hyd.) values for each amino acid were calculated by using an 11-residue moving window. A positive hydrophobicity 
value indicates a hydrophobic nature, Single and double asterisks indicate one and two standard deviations, respectively, above the average amphipathy of the Protein 
Identification Resource Database (1989). A plus sign indicates that the ll-residue window satisfies the criteria for membrane binding according to the method of 
Eisenberg el al. (19). At the top of the figure is shown the 7.5-kb single-stranded RNA genome of CBV3, containing (from 5' to 3') I lie 5' nontranslated region (NTR) 
with protein VPg covalently bound at its 5 ' end; the polyprotein-encoding region (boxed), which can be divided into the structural PI protein region and the 
nonstructural P2 and P3 protein regions; and the 3' NTR containing a polyadenylate tract at its 3' end.
and Edmundson (40) shows that this segment forms a putative 
amphipathic a-helix with a narrow hydrophilic face on one side 
of the helix (Fig. 2A). The distribution of charged residues 
(three lysines and one glutamic acid) on the hydrophilic face is 
well conserved among all enteroviruses, except that bovine 
enterovirus protein 2B contains arginines rather than lysines at 
positions 44 and 48 (Fig. 2A). The hydrophilic face of polio- 
virus protein 2B is somewhat larger because of the occurrence 
of polar asparagine and serine residues at aa 43 and 50, re­
spectively. On the basis of their physical-chemical and struc­
tural properties, amphipathic helices are grouped into seven 
classes (41). The arrangement of the charged residues in the 
putative amphipathic helix of CBV3 protein 2B is typical for 
the class of so-called lytic polypeptides. These lytic polypep­
tides form a group of small cationic amphipathic a-helical 
peptides that are characterized by narrow polar faces with 
intermediate charge densities, the occurrence of four times as 
many positively charged residues as negatively charged resi­
dues, and the occurrence of mainly lysine residues in the hy­
drophilic face (mean lysine/arginine ratio = 30). Figure 2B 
shows examples of helical wheel diagrams of two lytic polypep­
tides: bombolitin II (4) and mastoporan (23).
Construction of mutations in the putative amphipathic helix 
of CBV3 protein 2B. The function and the structural require­
ments of the putative amphipathic helix in CBV3 protein 2B 
were examined by a genetic analysis. A total of nine mutants, 
containing either substitution or insertion mutations, were gen­
erated by site-directed mutagenesis. The mutations were ver­
ified by sequence analysis and introduced in the infectious 
cDNA clone pCB3/T7. The genotype of the mutant plasmids 
and the effects of the mutations on mean hydrophobic moment 
and hydrophobicity are shown in Fig. 3A. Two mutants were 
constructed to examine the requirement for lysine residues at 
aa 41, 44, and 48. In these mutants, the lysine residues were 
replaced with either arginine residues (2B-K[41,44,48]R) or 
negatively charged glutamic acid residues (2B-K[41,44,48]E). 
Two mutant plasmids were constructed to examine the mini­
mal number of lysine residues required for the role of this 
domain in the function of protein 2B. In mutant 2B-K[41]L, 
lysine 41 is replaced with a leucine residue. In mutant 2B- 
K[41,44]L, both lysine 41 and lysine 44 are replaced with 
leucine residues. In the remaining two substitution mutants, 
the importance of the negatively charged glutamic acid 40 was 
examined. In these mutants, glutamic acid 40 was replaced with 
either a lysine (2B~E[40]K) or an aspartic acid (2B-E[40]D) 
residue. In the three insertion mutants (2B-ins[41]L, 2B- 
ins[44]L, and 2B-ins[48]L), hydrophobic leucine residues were 
introduced at aa 41, 44, and 48, respectively. The insertion of
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FIG. 2. (A) Helical wheel diagrams of the putative amphipathic helices found in the 2B proteins of several enteroviruses according to the method of Schiller and 
Edmundson (40). Positively charged (R and K) and negatively charged (D and E) residues are underlined. Hydrophobic amino acids arc boxed. Abbreviations: CBV, 
coxsackie B virus; CAV, coxsnckie A virus; ECHO, echovirus; SVDV, swine vesicular disease virus; PV, poliovirus; BEV, bovine enterovirus. (B) Helical wheel diagrams 
of lytic polypeptides bombolitin II, a heptadecapeptide isolated from the venom of bumblebee M. pennsylvanicus (4), and mastoporan, a tetradecapeptide isolated from 
the venom of the wasp Vcspula lewis it (23).
these residues leads to the dispersion of the charged residues 
and, as a consequence, the disruption of the narrow polar face 
°f the putative amphipathic helix (Fig. 3B), without disturbing 
the overall hydrophobicity of the domain (Fig. 3A).
Effect of the mutations on virus growth. The effect of the 
mutations on virus viability was studied by transfection of
BGM cells with RNA transcripts. For each mutant, eight trans­
fections were performed. After transfection, the cells were 
incubated at either 33 or 36°C. In case no virus growth was 
observed after 5 days, the cells were subjected to three cycles 
of freezing and thawing and 250 julI was passaged to fresh BGM 
cell monolayers, which were incubated for another three
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p l a s m i d a m i n o  a c i d s e q u e n c e
aa
mom.
37-54
h v d .
a a  4 0-50 
mom. h v d .
p l a q u e
D h e n o t v p e
pCB3/T7  Wt
- + + 
S I L E K S L K A L
40 45
+
V K I  X S A L V
5U
0. 54 0 .3 3 0 ,6 7 0 . 1 1
2 B - K [ 4 1 , 4 4 , 4 8 ] R 0 .6 9 0 . 1 6 0 .9 3 -0.  18 w i l d - t y p e
2 B - K [ 4 1 , 4 4 , 4 8 ] E 0 .43 0 . 4 6 0 .4 9 0 . 3 1 —
2B-K[4 1 ] L 0 .4 3 0 . 4 8 0 .4 8 0 .3 4 s m a l l
2 B - K [ 4 1 ,4 4 ] L 0 .3 0 0.  62 0 .2 7 0 .5 7 m i n u t e
2B-E [ 40 ] K 0 .5 6 0 . 2 9 0 .7 0 0 .0 4 - ,
2B - E [4 0 ] D 0 .5 3 0 .3 2 0 .6 8 0 .0 9 w i l d - t y p e
2 B - i n s [ 4 1 ] L 0 .3 0 0 .3 7 0 .4 5 0 .0 8 _
2 B - i n s [ 4 4 ] L 0 .3 7 0 .3 7 0 . 5 6 0 .0 8 -
2 B - i n s [ 4 8 ] L 0 .2 8 0 . 3 7 0 .4 2 0 .0 8 -
B
L.
_L» ♦
K
u
A
1
A A L A .1
FIG, 3. (A) Partial amino acid sequence (residues 37 to 54) and the hydrophobic moment and hydrop ho bicity values of the 213 proteins cncoded by wild-typo 
pCB3/T7 and the pCB3/T7-derived mutant plasmids. The effects of the mutations on the hydrophobic moment (mom.) and hydrophobicity (hyd.) of both the entire 
18-aa amphipathic helix and the most-amphipathic 11-aa segment (aa 40 to 50) are shown. Furthermore, the effects of the mutations on virus growth are .summarized. 
(B) Hclical wheel diagrams of the insertion mutants 2B-ins[41]L, 2B-ins[44]L, and 2B-ins[48]L, containing leucine insertions at residue positions 41, 44, and 48, 
respectively,
(36°C) or five (33°C) days. Viruses were obtained consistently 
with RNA transcripts carrying mutations K[41,44,48] R, K[41]L, 
K[41,44]L, and E[40]D. Plaque assays were performed, and 
four individual plaques were isolated from each mutant virus. 
Sequence analysis of the 2B coding region of these viruses 
showed that the mutations introduced by site-directed mu­
tagenesis were retained in the viral RNA and that no other 
amino acid replacements had occurred. These viruses were 
designated vCB3-2B-K[41,44,48]R, vCB3-2B-K[41]L, vCB3- 
2B-K[41,44]L, and vCB3-2B-E[40]D, respectively. No virus 
growth was observed upon transfection of BGM cells with 
RNA transcripts containing mutation K[41,44,48]E, ins[41]L, 
ins[44]L, or ins[48]L. To ensure that the nonviability of these 
mutations was not due to additional mutations in the plasmid 
DNA, new constructs carrying these mutations were made and 
RNA transcripts were assayed for their viability. Consistent 
with our initial results, no virus growth was observed following 
transfection.
Upon transfection with RNA transcripts of mutant 2B- 
E[40]K} virus growth was observed in only two of the eight 
transfected cultures. In one cell culture, virus growth was ob­
served on the second day posttransfection. Sequence analysis
virus yield (log TCID50/ml)
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FIG, 4. Single-cycle growth curves of wild-type and mutant viruses vCB3-2B- 
K[4l,44,48]R, vCB3-2B-K[41]L, vCB3-2B-K[41,44]L, and vCB3-2B-E[40]D.
BGM cells were infected at a MOl of 1, incubated a I 30°C, and harvested at 2, 
4, 6, and 8 h postinfection. Viruses were released from the infected cclls by three 
cycles of freezing and thawing, and the virus titers were determined by titration 
on BGM cclls at 36°C. TCID^o, 50% tissue culture infective dose,
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of the 2B coding region of these viruses showed that the in­
troduced lysine 40 (AAG) reverted to the original glutamic 
acid (GAG) by a single point mutation. No cytopathic effect 
was observed in the remaining seven transfected cell cultures. 
Upon passage of these cultures, however, virus growth became 
visible in one of the cultures grown at 33°C. Sequence analysis 
of the 2B coding region of these viruses showed that the in­
troduced lysine 40 (AAG) was retained in the viral RNA and 
that no other mutations had occurred. This finding was rather 
unexpected, because the lack of virus growth in the other 
cultures suggested that a reversion of the introduced mutation 
to a more favorable residue or a second-site compensating 
mutation in protein 2B had occurred. To investigate whether 
mutation E[40]K indeed allows virus growth and to exclude the 
possibility that the phenotype of the original mutation was 
influenced by an additional mutation elsewhere in the plasmid 
DNA, which might have arisen during plasmid construction, 
virus nt 3837 to 4238 (which were found to be identical tp those 
of plasmid 2B-E[40]K) were amplified, cut with Spel and 
BssEll, and cloned into wild-type pCB3/T7. BGM cells were 
transfected with RNA transcripts of several independently re­
constructed plasmids. However, no virus growth was observed 
in any of the transfected cell cultures, These data strongly 
suggest that mutation E[40]K is nonviable and that the viability 
and phenotype of the isolated virus are due to a second-site 
mutation outside 2B. For this reason, the virus was not in­
cluded in further characterization studies.
Viral growth characteristics were examined by plaque assay
B
4-
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K(41,44,48]E 
EI40IK 
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ina[48]l 
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hours after transfection
FIG. 5. Effects of the viable (A) and nonviable (B) mutations on the repli­
cation of chimeric lueifera.se replicón pCB3/T7-LUC BGM cells were trans­
fected with copy RNA transcripts of mutant replicona, and the luciferase activity 
was determined as described in Materials and Methods at the indicated times 
posttransfection. (C) Luciferase accumulation after transfection of BGM cells 
with copy RNA of mutant replicón pCB3/T7-LU C-bom II, which contains a 
substitution of protein 2B aa 40 to 54 by 15 amino acids of lytic peptide bom- 
bolitin II. Luciferase activity is measured in counts per minute.
and single-cycle growth analysis (at 33, 36, and 39°C). Mutant 
viruses vCB3-2B-K[41,44,48]R and vCB3-2B-E[40]D exhibited 
a wild-type growth at all temperatures. Mutant virus vCB3-2B~ 
K[41]L displayed a small-plaque phenotype. In single-cycle 
infections, this virus produced 20% of the wild-type virus yield 
at 8 h postinfection, irrespective of the temperature. Virus 
vCB3-2B-K[41,44]L exhibited a minute-plaque phenotype. 
This virus appeared to be slightly cold sensitive, as the virus 
yield was 1% of that of the wild-type virus at 36 and 39°C but 
only 0.05% of that of the wild-type virus at 33°C. Figure 4 
shows the viral growth curves of the mutant viruses at 36°C. 
The effects of the mutations on virus growth are summarized in 
Fig. 3.
Effect of the mutations on RNA replication. In a previous 
study, we reported the construction and use of chimeric sub- 
genomic replicon pCB3/T7-LUC, which carries the luciferase 
gene in place of the PI protein coding region, to study RNA 
replication (46). Upon transfection of BGM cells with RNA 
transcripts of pCB3/T7-LTJC, a triphasic pattern of luciferase 
accumulation was observed; luciferase activity increased as a 
result of translation of the input RNA (phase I), remained 
constant until the fifth hour posttransfection (phase II), and 
showed a second increase as a result of the translation of newly 
synthesized chimeric RNA strands (phase III). That luciferase 
accumulation indeed reflected viral RNA replication was dem­
onstrated by measuring replicon RNA levels by dot blot hy­
bridization (data not shown). To study the effect of the muta­
tions on RNA replication, the Spel-to-RssHIII fragments of 
the mutant plasmids were cloned in replicon pCB3/T7-LUC. 
BGM cells were transfected with RNA transcripts of the mu­
tant replicons, and luciferase activity was determined at 1,4, 6, 
8, and 10 h posttransfection. The effects of the viable mutations 
on RNA replication are shown in Fig. 5A. The introduction of 
mutation K[41]L resulted in a reduced level of RNA replica­
tion, as the increase in luciferase activity was only fourfold, 
whereas the increase in luciferase accumulation was 10- to 
20-foJd in the case of mutations K[41,44,48]R and E[40]D and 
wild-type pCB3/T7-LUC. Mutation K[41,44]L caused a more 
drastic reduction in RNA synthesis, as demonstrated by the
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FIG. 8. (A) Alignment of aa 37 lo 57 of CBV3 protein 213 with the amino acid sequence of cationic ct-helical lytic polypeptide bombolitin II (4). Positively charged 
(R and K) and negatively charged (D and E) residues are underlined. Hydrophobic amino acids are boxed. (B) Helical wheel diagrams showing the amphipathic 
a-helices (aa 37 to 54) oi wild-type CBV3 protein 2B (as encoded in plasmid pCB3/T7) and chimeric protein 2B encoded in plasmid 2B-bomII. In plasmid 2B-bomII, 
nt 3862 to 3906 (coding for a a 40 to 54) are replaced with 45 nt encoding the first 15 aa of bombolitin II.
labeled proteins translated from the mutant pCB3/T7 RNAs 
are shown in Fig. 6A. The results demonstrate that none of the 
mutations caused abnormalities in polyprotein processing. All 
cleavage products migrated with a correct mobility, and the 
translation patterns of all mutants were similar to that of wild- 
type pCB3/T7. Although it cannot be excluded that minor 
differences in the levels of the replication proteins contribute 
to the viral phenotypes, these results suggest that it is un­
likely that the defects in vRNA synthesis caused by the 
nonviable mutations K[41,44,48]E, E[40]K, ins[41]L, ins 
[44]L, and ins[48]L and the reductions in vRNA synthesis 
caused by the viable mutations K[41]L and K[41,44]L are 
due to defects in polyprotein processing.
Time course of protein synthesis in infected cells. The pos­
sibility that the reductions in virus yield and vRNA synthesis 
caused by mutations K[41]L and K[41,44]L are due to a re­
duced level of viral protein synthesis was considered. To ex­
amine this possibility, we studied viral protein synthesis in vivo. 
BGM cells were infected with either mutant or wild-type virus 
at a MOI of 25 and labeled with [35S]methionine for 30 min at 
various times postinfection. Figure 7 shows the electrophoretic 
analysis of the labeled proteins. From this figure, it can be seen 
that all viruses cause a similar shutoff of host protein synthesis 
but that viral protein synthesis is delayed in cells infected with 
the mutant viruses. Viral protein synthesis in wild-type-virus- 
infected cells peaks at 4 to 5 h postinfection and is inhibited 
from the sixth hour. In cells infected with the small-plaque 
virus vCB3-2B-K[41]L, viral protein synthesis peaks at 5 to 6 h 
postinfection, whereas in cells infected with the minute-plaque 
mutant vCB3-2B-K[41,44]L, viral protein synthesis is even de­
layed up to 6 to 7 h postinfection. These differences probably 
reflect a delayed growth of the mutant viruses and, as a result, 
a delay in cytopathic effect. Although viral protein synthesis is 
delayed in the mutant-infected cells, the level of viral protein 
synthesis is similar to that in wild-type-virus-infected cells, sug­
gesting that it is unlikely that the reductions in growth and
vRNA synthesis of these viruses are due to an impaired level of 
viral protein production.
Replacement of the amphipathic helix with lytic peptide 
bombolitin II. After having demonstrated that a cationic am­
phipathic a-helix is required for a function of protein 2B, we 
tested whether the a-helix could be functionally replaced by 
the cationic lytic polypeptide bombolitin II. Bombolitin II is a 
heptadecapeptide (Ser-Lys-Ile-Thr-Asp-Ile-Leu-Ala-Lys-Leu- 
Gly-Lys-Val-Leu-Ala-His-Val) identified in the venom of the 
bumblebee Megabombus pennsylvanicus (4). A helical wheel rep­
resentation of this peptide shows that it can form an amphi­
pathic cx-helix with a narrow polar face of six amino acids 
containing three lysine residues, one negatively charged aspar­
tic acid, and two polar residues (Fig. 2B). Alignment of the 
amino acid sequences of both helices showed that bombolitin
II resembles aa 40 to 56 of CBV3 protein 2B (Fig. 8A). We 
have replaced the nucleotide sequence encoding aa 40 to 54 
with a sequence encoding the first 15 aa of bombolitin II. The 
nucleotide sequence of the introduced PCR product was ver­
ified, and the resulting plasmid was designated 2B-bomIl. A 
helical wheel diagram of aa 37 to 54 of this chimeric plasmid is 
shown in Fig. 8B. In vitro translation of RNA from this plasmid 
showed a processing pattern that was similar to that produced 
by wild-type pCB3/T7 RNA (Fig. 6B). To study the viability of 
this chimeric construct, BGM cells were transfected with T7 
RNA polymerase-generated RNA transcripts. A total of 10 
transfections, including passage of the transfected cell cultures 
to fresh cells, was performed. In none of the transfected cell 
cultures, however, was virus growth observed. The Spel-to- 
BssH ll fragment of 2B-bomII was introduced in subgenomic 
replicon pCB3/T7-LUC to study RNA replication. Analysis of 
luciferase accumulation following the transfection of BGM 
cells with copy RNA transcripts demonstrated a defect in rep­
lication of the replicon RNA (Fig. 5C). This finding suggests 
that despite the structural similarities between the amphipathic 
helix motifs, the cationic a-helix of bombolitin II cannot fulfill
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the function of the cationic amphipathic a-helix of CBV3 pro­
tein 2B in vRNA synthesis.
DISCUSSION
Membrane permeabilization is a phenomenon that occurs 
during the late phase of the replication cycle of most cytolytic 
viruses. This modification of the membrane is dependent on 
viral gene expression. A number of viral proteins involved in 
modifying membrane permeability have been identified in re­
cent years, and a general term for this kind of proteins has 
been introduced: viroporins (13), A general feature of these 
viroporins is the presence of amphipathic helix motifs, which 
are thought to destabilize the membrane integrity by interact­
ing with the lipid bilayer. Until recently, the identity of an 
enterovirus viroporin was unknown. Upon expression of the 
poliovirus nonstructural proteins in Escherichia coli, it was 
found that both proteins 2B and 3A modified the bacterial cell 
membrane (31). Very recently, it has been shown that polio­
virus protein 2B, but not protein 3A, permeabilizes the plasma 
membrane in eucaryotic cells (16), suggesting that protein 2B 
is most probably the enterovirus viroporin. Consistent with this 
idea, we have identified an amphipathic helix motif in protein 
2B that is conserved among all enteroviruses (Fig. 2A). The 
arrangement of charged residues in a narrow hydrophilic face 
and the predominant occurrence of cationic lysine residues are 
typical of amphipathic helices formed by members of the class 
of lytic polypeptides.
In this study, we have examined the functional and structural 
roles of the putative amphipathic helix in CBV3 protein 2B. 
Nine mutant cDNAs were constructed by site-directed mu­
tagenesis. The results obtained with the mutants carrying sub­
stitutions of the lysine residues (aa 41, 44, and 48) suggest that 
cationic residues are required for the role of the amphipathic 
helix in the function of protein 2B, Replacement of the lysine 
residues with arginine residues (K[41,44,48]R) did not affect 
virus growth, whereas substitution of the lysine residues with 
negatively charged glutamic acid residues (K[41,44,48]E) was 
nonviable because of defects in vRNA replication. Substitution 
of lysine 41 by a leucine residue (K[41]L) yielded a small- 
plaque virus that produced 20% of the wild-type virus yield in 
a single-cycle infection, because of a reduction in vRNA syn­
thesis. Substitution of both lysine 41 and lysine 44 by leucine 
residues (K[41,44]L) yielded a minute-plaque virus that pro­
duced only 1% of the wild-type virus yield in a single-cycle 
infection, because of a more severe defect in vRNA synthesis. 
These results suggest that the presence of cationic residues is 
a major determinant of the function of the amphipathic helix in 
protein 2B. The introduction of negatively charged residues in 
the hydrophilic face of the helix disrupts the function of pro­
tein 2B, although the amphipathic helix containing mutation 
K[41,44,48]E displays a hydrophobic moment that is equal to 
or even larger than the moments of the helices containing 
mutation K[41]L or K[41,44]L, respectively (Fig. 3A).
Two substitution mutations were introduced to investigate 
the importance of the negatively charged glutamic acid 40 in 
the function of the amphipathic helix. The introduction of a 
lysine residue (E[40]K) was highly detrimental for virus 
growth, although this mutation has virtually no effect on the 
amphipathy of the a-helix (Fig. 3A). Viruses containing this 
mutation were isolated on only one occasion. The failure to 
recover viruses from simultaneously transfected cell cultures 
suggested that a second-site compensating mutation might 
have occurred. No such mutation was found in protein 2B. 
Reconstruction of the mutation into wild-type cDNA followed 
by transfection of cells with RNA transcripts of the resulting
clones did not give rise to virus growth. These data are indic­
ative of the occurrence of an additional second-site mutation 
outside 2B. Experiments to test this possibility are currently in 
progress. The wild-type growth characteristics of viruses car­
rying a replacement of glutamic acid 40 with a negatively 
charged aspartic acid (E[40]D) demonstrate that a negatively 
charged residue is preferred at this position. The reason for the 
preference for a negatively charged residue in the hydrophilic 
face of this cationic amphipathic a-helix is unknown. None of 
the substitution mutations interfered with viral protein synthe­
sis and polyprotein processing, indicating that the effects of 
these mutations on virus growth are primarily attributable to 
defects in vRNA replication.
The importance of the amphipathic character of the helix for 
the function of protein 2B was demonstrated by characteriza­
tion of the three insertion mutants. Leucine residues were 
inserted between the charged residues (ins[41]L, ins[44]L, and 
ins[48]L), such that the amphipathy of the a-helix was severely 
disturbed whereas its mean hydrophobicity was unaffected. 
These mutations caused severe defects in vRNA synthesis and 
were all nonviable. The hydrophobic moments of these helices 
were similar to that containing mutation K[41,44]L (Fig. 3A). 
A main difference, however, is that because of the insertion 
mutations, the charged residues are dispersed and even located 
in the hydrophobic part of the helix, which probably interferes 
with the hydrophobic interaction with the membrane, whereas 
the narrow hydrophilic face and the hydrophobic part of the 
a-helix are maintained by mutation K[41,44]L. None of the 
insertion mutations affected the synthesis and processing of the 
viral protein, indicating that they primarily affected vRNA 
synthesis. Altogether, the results obtained with both the sub­
stitution and insertion mutants suggest that an amphipathic 
a-helix containing predominantly cationic lysine residues in a 
narrow hydrophilic face is a major structural determinant in­
volved in a function of protein 2B, and possibly its precursor 
2BC, in vRNA replication.
The structure of the cationic amphipathic a-helices found in 
enterovirus protein 2B shows close similarities to that of the 
cationic amphipathic a-helical peptides that form the class of 
lytic polypeptides (41). Most of these short cationic lytic 
polypeptides have been identified in the venom of insects or 
the skin of amphibia and are involved in an antibacterial de­
fense system. Two models of action have emerged from the 
structural and functional studies on these peptides (reviewed 
in reference 6). In one model, the cytolytic helices form aque­
ous channels by spanning the membrane and forming oli­
gomers, exposing their hydrophobic sides to the lipid bilayer 
and their hydrophilic faces to the aqueous pores. Although 
anion selectivity may be predicted, membrane currency mea­
surements have demonstrated that cationic peptides can form 
either anion-selective (15, 17, 45) or cation-selective ion chan­
nels (1, 24, 44). These channels produce ionic imbalances 
which will ultimately result in colloid osmotic lysis. A second 
model proposes that these peptides produce lysis by disrupting 
the phospholipid structure of the membrane by lying parallel 
to the membrane and perturbing the membrane, making the 
membrane phospholipids more susceptible to enzymatic deg­
radation by phospholipases (6,41). The resulting lesions in the 
membrane would allow a flux of ions, causing the ionic imbal­
ances that are responsible for lysis of the cell.
The modification of the plasma membrane that occurs dur­
ing an enterovirus infection is such that both gradients of 
sodium and potassium are disturbed and small nonpermeative 
translation inhibitors like hygromycin B and edeine can enter 
the virus-infected cells (13). Later in infection, the cellular 
membrane becomes more severely disrupted, and enzymes and
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sugars can also leak out of the infccted cells (13). The initial 
permeability of the plasma membrane for both monovalent 
cations and small translation inhibitors suggests that pores or 
membrane lesions, rather than a specific ion pump, are 
formed. By analogy with the lytic polypeptides, protein 2B may 
form transmembrane cation-selective pores or lie collateral to 
the membrane, making the phospholipids more accessible to 
the action of phospholipases. Both mechanisms would account 
for the observed ion fluxes across the membrane, causing the 
ionic imbalances that may be responsible for a further desta­
bilization of the membrane. Many cytolytic viruses have been 
reported to increase phospholipase activity. In poliovirus-in- 
fected cells, choline and phosphorylcholine are released in the 
culture medium and the levels of diacylglycerol and inositol 
triphosphate in the cytoplasm are increased from the third 
hour postinfection (21). Although this finding suggests that the 
membrane modification may be caused by phospholipases, the 
possibilities that protein 2B still forms transmembrane pores 
and that the integration of these pores is responsible for dis­
turbing the integrity of the membrane and the activation of the 
phospholipases cannot be excluded.
Although protein 2B has a profound effect on the perme­
ability of the plasma membrane, it should be emphasized that 
there is no experimental proof for an interaction of protein 2B 
with the plasma membrane. Electron microscopic studies using 
immunocytochemistry have shown that proteins 2B, 2C, and 
2BC of poliovirus are contained exclusively at the endoplasmic 
reticulum membrane or the surface of the endoplasmic retic- 
ulum-derived membrane vesicles that surround the viral rep­
lication complexes (8). Intracellular localization of individual 
expressed poliovirus protein 2B in eucaryotic cells showed a 
disseminated distribution throughout the cytoplasm (2). These 
findings suggest that protein 2B interacts with intracellular 
membranes rather than with the plasma membrane. On the 
basis of these observations, an alternative mechanism for the 
induction of the plasma membrane modification may be pro­
posed. Because of its ionophoric or membrane-perturbing 
properties, protein 2B may permeabilize endoplasmic reticu­
lum membranes and cause the leakage of stored calcium ions 
into the cytosol. The consequences of a permanent increase in 
cytosolic calcium concentration for cellular metabolism and 
virus reproduction are unknown. However, as calcium is a 
regulator of a broad spectrum of physiological processes, it is 
likely that an increased calcium level is highly toxic for an array 
of cellular structures and processes. Increased cytosolic cal­
cium levels in rotavirus (32), Semliki Forest virus (37), cyto­
megalovirus (34), and recently also in poliovirus-infected cells
(25) have been demonstrated. The possible role of the alter­
ations in calcium ion concentrations in viral replication, mem­
brane permeabiiization, and cell lysis, however, remains to be 
elucidated.
Mutations that disrupt the cationic amphipathic a-helix in 
protein 2B cause primary defects in vRNA synthesis, suggest­
ing that the initial consequence of the membrane modification 
(i.e., the efflux of potassium ions and the influx of sodium ions 
or, alternatively, the efflux of calcium) is a prerequisite for 
vRNA replication. However, the possibility that the cationic 
amphipathic helix is also required for the second function that 
has been attributed to protein 2B, i.e., the inhibition of cellular 
protein secretion, cannot be excluded. It has been proposed 
that this inhibition is involved in the accumulation of mem­
brane vesicles on which positive-strand RNA synthesis occurs 
(16). Permeabilization of membranes may be required for this 
function, by causing either an altered ionic environment that 
may be inhibitory to protein transport or a nonspecific leaki­
ness of intracellular organelle membranes and the loss of mol­
ecules crucial for transport. A disruption of the cationic am­
phipathic helix may interfere with the accumulation of the 
virus-induced membrane vesicles that are required for the for­
mation of the viral replication complexes and thereby may be 
responsible for the defects in vRNA replication.
Although the results presented in this paper indicate that the 
cationic amphipathic a-helix in protein 2B is an important 
requirement for its function in vRNA synthesis, replacement of 
this structural motif with the cationic amphipathic helix of lytic 
peptide bombolitin II resulted in a nonfunctional protein 2B. 
Both amphipathic helices contain a small hydrophilic face 
formed by three lysines, one negatively charged residue, and 
two polar residues (Fig. 2). The nonviability of this chimeric 
construct (2B-bomII) suggests that the position of the charged 
residues in the helix may be crucial either for the formation of 
a cation-specific pore or for the membrane-perturbing capac­
ity. Alternatively, alterations in the amino acid sequence of this 
domain may interfere with a possible interaction of the puta­
tive amphipathic helix with another membrane-interacting do­
main of CBV3 protein 2B. Potential candidates for such an 
interaction are the N-terminal 16 aa, which also have consid­
erable potential to form an amphipathic a-helix (Fig, 1), and 
the hydrophobic domain, formed by aa 63 to 80, which contains 
an amino acid composition and hydrophobicity features that 
are characteristic of multimeric transmembrane regions (46). 
Either of these domains may, together with the cationic am­
phipathic a-helix, cooperatively be involved in the formation of 
a cation-specific pore. Additional mutational analysis and anal­
ysis of the effects of individually expressed mutant 2B proteins 
on membrane permeability and protein secretion are required 
for a better understanding of the involvement of protein 2B in 
membrane modification and virus replication.
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